Please login (Members) to view content or
(Nonmembers) this article.
0
No votes yet
Cochrane Nursing Care Field

Histamine Type 2 Receptor Antagonists as Adjuvant Treatment for Resected Colorectal Cancer

Karolina Lisy
CJON 2013, 17(2), 211-212 DOI: 10.1188/13.CJON.211-212

Objective: To assess whether histamine type 2 receptor antagonists (H2RAs) improve overall survival when used as pre-, peri-, or postoperative therapy in patients with colorectal cancer who had surgical resection with curative intent.

Members Only

Access to this article is restricted. Please login to view the full article.

Not a current ONS Member or journal subscriber?
Join/Renew Membership or